← Back
$RXRX All transactions

RECURSION PHARMACEUTICALS, INC.

C 10b5-1 Plan

$ Value

$0

Shares

60,000

Price

$0

Filed

Nov 6

Insider

Name

Gibson Christopher

Title

Chief Executive Officer

CIK

0001856369

Roles

Director Officer

Transaction Details

Transaction Date

2025-11-04

Code

C

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,014,229

Footnotes

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. | This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025. | The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. | The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. | The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. | The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. | The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. | The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. | The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. | The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.

Filing Info

Accession No.

0001856369-25-000012

Form Type

4

Issuer CIK

0001601830

Gibson Christopher's History

Date Ticker Type Value
2026-04-08 PACB A $0
2026-04-08 PACB A $0
2026-04-07 RXRX C $0
2026-04-07 RXRX $124K
2026-04-07 RXRX C $0
2026-03-23 RXRX C $0
2026-03-23 RXRX $130K
2026-03-23 RXRX C $0
2025-12-19 RXRX C $0
2025-12-19 RXRX $180K

Other Insiders at RXRX (90d)

Insider Bought Sold Last
Taylor Ben R
Chief Financial Officer
2026-04-06
Li Dean Y 2026-04-01
Dar Zavain 2026-04-01
Borgeson Blake $93K 2026-04-07
Gibson Christopher $254K 2026-04-07